Chembio Diagn (CEMI) Tops Q2 EPS by 1c

Chembio Diagn (NASDAQ: CEMI) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $6.08 million versus the consensus estimate of $6.36 million.

For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance